biospecimen_aliquot__bcr_aliquot_barcode	tcga-d8-a143-01a-11d-a10y-09
biospecimen_aliquot__bcr_aliquot_uuid	db1763d1-fcae-4a01-a0cb-3019e292aa10
biospecimen_aliquot__bcr_patient_uuid	1c40b84e-a0e3-429f-a48c-21566cf881c0
biospecimen_aliquot__bcr_sample_barcode	tcga-d8-a143-01a
biospecimen_aliquot__biospecimen_barcode_bottom	0100490454
biospecimen_aliquot__center_id	09
biospecimen_aliquot__concentration	0.07
biospecimen_aliquot__date_of_shipment	2011-01-12
biospecimen_aliquot__is_derived_from_ffpe	no
biospecimen_aliquot__plate_column	9
biospecimen_aliquot__plate_id	a10y
biospecimen_aliquot__plate_row	g
biospecimen_aliquot__quantity	1.82
biospecimen_aliquot__source_center	23
biospecimen_aliquot__volume	26.00
biospecimen_analyte__a260_a280_ratio	2.40
biospecimen_analyte__analyte_type	dna
biospecimen_analyte__analyte_type_id	d
biospecimen_analyte__bcr_analyte_barcode	tcga-d8-a143-01a-11d
biospecimen_analyte__bcr_analyte_uuid	bf56fb16-b692-4c4b-a321-487407e70198
biospecimen_analyte__bcr_patient_uuid	1c40b84e-a0e3-429f-a48c-21566cf881c0
biospecimen_analyte__bcr_sample_barcode	tcga-d8-a143-01a
biospecimen_analyte__concentration	0.15
biospecimen_analyte__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen_analyte__is_derived_from_ffpe	no
biospecimen_analyte__normal_tumor_genotype_match	yes
biospecimen_analyte__pcr_amplification_successful	yes
biospecimen_analyte__spectrophotometer_method	uv spec
biospecimen_analyte__subportion_sequence	1
biospecimen_diagnostic_slides__bcr_patient_barcode	tcga-d8-a143
biospecimen_diagnostic_slides__bcr_patient_uuid	1c40b84e-a0e3-429f-a48c-21566cf881c0
biospecimen_diagnostic_slides__bcr_sample_barcode	tcga-d8-a143-01a
biospecimen_diagnostic_slides__ffpe_slide_uuid	4697fb2f-91d5-4506-af23-7de304d44a3f
biospecimen_normal_control__bcr_patient_barcode	tcga-d8-a143
biospecimen_normal_control__bcr_patient_uuid	1c40b84e-a0e3-429f-a48c-21566cf881c0
biospecimen_portion__bcr_patient_uuid	1c40b84e-a0e3-429f-a48c-21566cf881c0
biospecimen_portion__bcr_portion_barcode	tcga-d8-a143-01a-11
biospecimen_portion__bcr_portion_uuid	58ca7f53-3c1c-410e-946a-e6c2970b7552
biospecimen_portion__bcr_sample_barcode	tcga-d8-a143-01a
biospecimen_portion__date_of_creation	2010-12-09
biospecimen_portion__is_ffpe	no
biospecimen_portion__portion_number	11
biospecimen_portion__portion_sequence	1
biospecimen_portion__weight	30.00
biospecimen_protocol__bcr_analyte_barcode	tcga-d8-a143-01a-11d
biospecimen_protocol__bcr_patient_uuid	1c40b84e-a0e3-429f-a48c-21566cf881c0
biospecimen_protocol__bcr_sample_barcode	tcga-d8-a143-01a
biospecimen_protocol__experimental_protocol_type	adna preparation type
biospecimen_sample__bcr_patient_uuid	1c40b84e-a0e3-429f-a48c-21566cf881c0
biospecimen_sample__bcr_sample_barcode	tcga-d8-a143-01a
biospecimen_sample__bcr_sample_uuid	1bab00ca-778e-48ac-ac59-ce2b99d84403
biospecimen_sample__days_to_collection	211
biospecimen_sample__initial_weight	200
biospecimen_sample__is_ffpe	no
biospecimen_sample__oct_embedded	false
biospecimen_sample__pathology_report_file_name	tcga-d8-a143.f8c2f3ef-fa73-4ff8-9a4e-7f557e68d560.pdf
biospecimen_sample__pathology_report_uuid	f8c2f3ef-fa73-4ff8-9a4e-7f557e68d560
biospecimen_sample__sample_type	primary tumor
biospecimen_sample__sample_type_id	01
biospecimen_sample__vial_number	a
biospecimen_shipment_portion__bcr_patient_uuid	1c40b84e-a0e3-429f-a48c-21566cf881c0
biospecimen_shipment_portion__bcr_sample_barcode	tcga-d8-a143-01a
biospecimen_shipment_portion__bcr_shipment_portion_uuid	e9cd47fb-4a8f-44c9-af6a-f931387d14a7
biospecimen_shipment_portion__center_id	20
biospecimen_shipment_portion__is_ffpe	no
biospecimen_shipment_portion__plate_id	a13d
biospecimen_shipment_portion__portion_number	21
biospecimen_shipment_portion__portion_sequence	2
biospecimen_shipment_portion__shipment_portion_bcr_aliquot_barcode	tcga-d8-a143-01a-21-a13d-20
biospecimen_shipment_portion__shipment_portion_day_of_shipment	22
biospecimen_shipment_portion__shipment_portion_month_of_shipment	3
biospecimen_shipment_portion__shipment_portion_year_of_shipment	2011
biospecimen_slide__bcr_patient_uuid	1c40b84e-a0e3-429f-a48c-21566cf881c0
biospecimen_slide__bcr_sample_barcode	tcga-d8-a143-01a
biospecimen_slide__bcr_slide_barcode	tcga-d8-a143-01a-01-bsa
biospecimen_slide__bcr_slide_uuid	0b346101-acfa-429f-a30d-3ed544719c7a
biospecimen_slide__image_file_name	tcga-d8-a143-01a-01-bsa.0b346101-acfa-429f-a30d-3ed544719c7a.svs
biospecimen_slide__is_derived_from_ffpe	no
biospecimen_slide__percent_lymphocyte_infiltration	70
biospecimen_slide__percent_monocyte_infiltration	10
biospecimen_slide__percent_necrosis	5
biospecimen_slide__percent_neutrophil_infiltration	10
biospecimen_slide__percent_normal_cells	0
biospecimen_slide__percent_stromal_cells	25
biospecimen_slide__percent_tumor_cells	70
biospecimen_slide__percent_tumor_nuclei	80
biospecimen_slide__section_location	bottom
biospecimen_tumor_sample__bcr_patient_barcode	tcga-d8-a143
biospecimen_tumor_sample__bcr_patient_uuid	1c40b84e-a0e3-429f-a48c-21566cf881c0
clinical_drug__bcr_drug_barcode	tcga-d8-a143-d13818
clinical_drug__bcr_drug_uuid	786a632d-1981-4d67-b28c-dfea95e74cca
clinical_drug__bcr_patient_barcode	tcga-d8-a143
clinical_drug__bcr_patient_uuid	1c40b84e-a0e3-429f-a48c-21566cf881c0
clinical_drug__form_completion_date	2011-7-4
clinical_drug__pharma_adjuvant_cycles_count	6
clinical_drug__pharmaceutical_therapy_drug_name	doxorubicin
clinical_drug__pharmaceutical_therapy_type	chemotherapy
clinical_drug__pharmaceutical_tx_dose_units	mg/m2
clinical_drug__pharmaceutical_tx_ended_days_to	172
clinical_drug__pharmaceutical_tx_ongoing_indicator	no
clinical_drug__pharmaceutical_tx_started_days_to	67
clinical_drug__pharmaceutical_tx_total_dose_units	mg/m2
clinical_drug__prescribed_dose	60
clinical_drug__regimen_number	ac
clinical_drug__route_of_administration	iv
clinical_drug__therapy_regimen	adjuvant
clinical_follow_up__bcr_followup_barcode	tcga-d8-a143-f13817
clinical_follow_up__bcr_followup_uuid	a3f360db-0bef-4cc5-8175-d859a234af9e
clinical_follow_up__bcr_patient_barcode	tcga-d8-a143
clinical_follow_up__bcr_patient_uuid	1c40b84e-a0e3-429f-a48c-21566cf881c0
clinical_follow_up__followup_reason	scheduled follow-up submission
clinical_follow_up__form_completion_date	2011-7-4
clinical_follow_up__last_contact_days_to	431
clinical_follow_up__new_tumor_event_dx_indicator	no
clinical_follow_up__radiation_treatment_adjuvant	no
clinical_follow_up__targeted_molecular_therapy	yes
clinical_follow_up__tumor_status	tumor free
clinical_follow_up__vital_status	alive
clinical_patient__age_at_diagnosis	51
clinical_patient__ajcc_metastasis_pathologic_pm	m0
clinical_patient__ajcc_nodes_pathologic_pn	n0
clinical_patient__ajcc_pathologic_tumor_stage	stage iia
clinical_patient__ajcc_staging_edition	7th
clinical_patient__ajcc_tumor_pathologic_pt	t2
clinical_patient__anatomic_neoplasm_subdivision	left lower inner quadrant
clinical_patient__axillary_staging_method	axillary lymph node dissection alone
clinical_patient__bcr_patient_barcode	tcga-d8-a143
clinical_patient__bcr_patient_uuid	1c40b84e-a0e3-429f-a48c-21566cf881c0
clinical_patient__birth_days_to	-18984
clinical_patient__days_to_initial_pathologic_diagnosis	0
clinical_patient__er_status_by_ihc	negative
clinical_patient__ethnicity	not hispanic or latino
clinical_patient__form_completion_date	2011-2-25
clinical_patient__gender	female
clinical_patient__her2_ihc_score	1+
clinical_patient__her2_status_by_ihc	negative
clinical_patient__histological_type	infiltrating ductal carcinoma
clinical_patient__history_neoadjuvant_treatment	no
clinical_patient__history_other_malignancy	no
clinical_patient__icd_10	c50.9
clinical_patient__icd_o_3_histology	8500/3
clinical_patient__icd_o_3_site	c50.9
clinical_patient__informed_consent_verified	yes
clinical_patient__initial_pathologic_dx_year	2010
clinical_patient__last_contact_days_to	172
clinical_patient__lymph_nodes_examined	yes
clinical_patient__lymph_nodes_examined_count	11
clinical_patient__lymph_nodes_examined_he_count	0
clinical_patient__margin_status	negative
clinical_patient__menopause_status	post (prior bilateral ovariectomy or >12 mo since lmp with no prior hysterectomy)
clinical_patient__method_initial_path_dx	core needle biopsy
clinical_patient__micromet_detection_by_ihc	no
clinical_patient__patient_id	a143
clinical_patient__pr_status_by_ihc	negative
clinical_patient__prospective_collection	yes
clinical_patient__race	white
clinical_patient__retrospective_collection	no
clinical_patient__surgical_procedure_first	modified radical mastectomy
clinical_patient__tissue_source_site	d8
clinical_patient__tumor_status	tumor free
clinical_patient__tumor_tissue_site	breast
clinical_patient__vital_status	alive
manually_curated__center	genome.wustl.edu
manually_curated__dataType	dnaseq
manually_curated__exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-D8-A143-01A-11D-A10Y-09.bed
manually_curated__exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-D8-A143-01A-11D-A10Y-09.bed.meta
manually_curated__id	tcga-d8-a143-01a-11d-a10y-09
manually_curated__md5sum	6a3c152e5d29f84e8aca67cc70c94129
manually_curated__ncbi_build	37
manually_curated__seqPlatform	illumina_ga2
manually_curated__sequence_source	wxs
manually_curated__sequencer	illumina gaiix
manually_curated__tissue_status	tumoral
manually_curated__tumor_description	breast invasive carcinoma
manually_curated__tumor_sample_uuid	db1763d1-fcae-4a01-a0cb-3019e292aa10
manually_curated__tumor_tag	brca
